Institutional investors may adopt severe steps after Orthofix Medical Inc.'s (NASDAQ:OFIX) latest 15% drop adds to a year losses

Advertisement

Key Insights

  • Institutions' substantial holdings in Orthofix Medical implies that they have significant influence over the company's share price
  • A total of 7 investors have a majority stake in the company with 52% ownership
  • Recent purchases by insiders

Every investor in Orthofix Medical Inc. (NASDAQ:OFIX) should be aware of the most powerful shareholder groups. The group holding the most number of shares in the company, around 54% to be precise, is institutions. Put another way, the group faces the maximum upside potential (or downside risk).

And institutional investors endured the highest losses after the company's share price fell by 15% last week. The recent loss, which adds to a one-year loss of 13% for stockholders, may not sit well with this group of investors. Also referred to as "smart money", institutions have a lot of sway over how a stock's price moves. As a result, if the downtrend continues, institutions may face pressures to sell Orthofix Medical, which might have negative implications on individual investors.

Let's take a closer look to see what the different types of shareholders can tell us about Orthofix Medical.

See our latest analysis for Orthofix Medical

ownership-breakdown
NasdaqGS:OFIX Ownership Breakdown May 7th 2025

What Does The Institutional Ownership Tell Us About Orthofix Medical?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

Orthofix Medical already has institutions on the share registry. Indeed, they own a respectable stake in the company. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Orthofix Medical's earnings history below. Of course, the future is what really matters.

earnings-and-revenue-growth
NasdaqGS:OFIX Earnings and Revenue Growth May 7th 2025

Investors should note that institutions actually own more than half the company, so they can collectively wield significant power. It would appear that 33% of Orthofix Medical shares are controlled by hedge funds. That's interesting, because hedge funds can be quite active and activist. Many look for medium term catalysts that will drive the share price higher. Rubric Capital Management LP is currently the company's largest shareholder with 9.5% of shares outstanding. Engine Capital Management, LP is the second largest shareholder owning 9.3% of common stock, and BlackRock, Inc. holds about 7.8% of the company stock.

We also observed that the top 7 shareholders account for more than half of the share register, with a few smaller shareholders to balance the interests of the larger ones to a certain extent.

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too.

Insider Ownership Of Orthofix Medical

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.

We can see that insiders own shares in Orthofix Medical Inc.. It has a market capitalization of just US$528m, and insiders have US$15m worth of shares, in their own names. This shows at least some alignment. You can click here to see if those insiders have been buying or selling.

General Public Ownership

The general public-- including retail investors -- own 11% stake in the company, and hence can't easily be ignored. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

Next Steps:

It's always worth thinking about the different groups who own shares in a company. But to understand Orthofix Medical better, we need to consider many other factors. Be aware that Orthofix Medical is showing 1 warning sign in our investment analysis , you should know about...

Ultimately the future is most important. You can access this free report on analyst forecasts for the company.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NasdaqGS:OFIX

Orthofix Medical

Operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally.

Undervalued with adequate balance sheet.

Advertisement

Weekly Picks

TA
Talos
TSLA logo
Talos on Tesla ·

The "Physical AI" Monopoly – A New Industrial Revolution

Fair Value:US$665.3635.6% undervalued
25 users have followed this narrative
14 users have commented on this narrative
16 users have liked this narrative
MA
CSG logo
Marek_Trnka on CSG ·

Czechoslovak Group - is it really so hot?

Fair Value:€5547.0% undervalued
34 users have followed this narrative
1 users have commented on this narrative
13 users have liked this narrative
AL
alex30free
SECARE logo
alex30free on Swedencare ·

The Compound Effect: From Acquisition to Integration

Fair Value:SEK 46.2846.5% undervalued
9 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative

Updated Narratives

CO
Coward_Nutlick
ELTX logo
Coward_Nutlick on Elicio Therapeutics ·

Very Bullish

Fair Value:US$10091.6% undervalued
12 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative
DM
DMXS
EEE logo
DMXS on Coca-Cola HBC ·

A Tale of Two Engines: Coca-Cola HBC (EEE.AT)

Fair Value:€576.1% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
CO
composite32
TTE logo
composite32 on TotalEnergies ·

This strategic transformation of TTE? Significant re-rating potential

Fair Value:€68.56.1% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OO
NEO logo
OOO97 on Neo Performance Materials ·

Undervalued Key Player in Magnets/Rare Earth

Fair Value:CA$25.3317.2% undervalued
78 users have followed this narrative
0 users have commented on this narrative
20 users have liked this narrative
DA
davidlsander
UBI logo
davidlsander on Ubisoft Entertainment ·

Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share

Fair Value:€33.887.8% undervalued
57 users have followed this narrative
5 users have commented on this narrative
25 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$603.2233.0% undervalued
1267 users have followed this narrative
2 users have commented on this narrative
9 users have liked this narrative

Trending Discussion

Advertisement